SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR

KennethJ Leveno, DavidS Guzick, GaryD V. Hankins, VictorR Klein, DavidC Young, M. Lynne Williams

Research output: Contribution to journalArticle

68 Citations (Scopus)

Abstract

106 women between 24 and 33 weeks' gestation and in preterm labour, rigidly defined to include cervical dilatation plus regular uterine contractions, were randomly allocated to receive either intravenous ritodrine hydrochloride or no tocolytic treatment. Ritodrine treatment significantly delayed delivery for 24 hours or less but did not significantly modify the ultimate perinatal consequences of preterm labour.

Original languageEnglish (US)
Pages (from-to)1293-1296
Number of pages4
JournalThe Lancet
Volume327
Issue number8493
DOIs
StatePublished - Jun 7 1986

Fingerprint

Ritodrine
Premature Obstetric Labor
Tocolysis
First Labor Stage
Uterine Contraction
Pregnancy
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Leveno, K., Guzick, D., Hankins, G. V., Klein, V., Young, D., & Williams, M. L. (1986). SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR. The Lancet, 327(8493), 1293-1296. https://doi.org/10.1016/S0140-6736(86)91219-5

SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR. / Leveno, KennethJ; Guzick, DavidS; Hankins, GaryD V.; Klein, VictorR; Young, DavidC; Williams, M. Lynne.

In: The Lancet, Vol. 327, No. 8493, 07.06.1986, p. 1293-1296.

Research output: Contribution to journalArticle

Leveno, K, Guzick, D, Hankins, GV, Klein, V, Young, D & Williams, ML 1986, 'SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR', The Lancet, vol. 327, no. 8493, pp. 1293-1296. https://doi.org/10.1016/S0140-6736(86)91219-5
Leveno, KennethJ ; Guzick, DavidS ; Hankins, GaryD V. ; Klein, VictorR ; Young, DavidC ; Williams, M. Lynne. / SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR. In: The Lancet. 1986 ; Vol. 327, No. 8493. pp. 1293-1296.
@article{1f76f3fb16704cd59292f471c8c1c28c,
title = "SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR",
abstract = "106 women between 24 and 33 weeks' gestation and in preterm labour, rigidly defined to include cervical dilatation plus regular uterine contractions, were randomly allocated to receive either intravenous ritodrine hydrochloride or no tocolytic treatment. Ritodrine treatment significantly delayed delivery for 24 hours or less but did not significantly modify the ultimate perinatal consequences of preterm labour.",
author = "KennethJ Leveno and DavidS Guzick and Hankins, {GaryD V.} and VictorR Klein and DavidC Young and Williams, {M. Lynne}",
year = "1986",
month = "6",
day = "7",
doi = "10.1016/S0140-6736(86)91219-5",
language = "English (US)",
volume = "327",
pages = "1293--1296",
journal = "The Lancet",
issn = "0140-6736",
publisher = "Elsevier Limited",
number = "8493",

}

TY - JOUR

T1 - SINGLE-CENTRE RANDOMISED TRIAL OF RITODRINE HYDROCHLORIDE FOR PRETERM LABOUR

AU - Leveno, KennethJ

AU - Guzick, DavidS

AU - Hankins, GaryD V.

AU - Klein, VictorR

AU - Young, DavidC

AU - Williams, M. Lynne

PY - 1986/6/7

Y1 - 1986/6/7

N2 - 106 women between 24 and 33 weeks' gestation and in preterm labour, rigidly defined to include cervical dilatation plus regular uterine contractions, were randomly allocated to receive either intravenous ritodrine hydrochloride or no tocolytic treatment. Ritodrine treatment significantly delayed delivery for 24 hours or less but did not significantly modify the ultimate perinatal consequences of preterm labour.

AB - 106 women between 24 and 33 weeks' gestation and in preterm labour, rigidly defined to include cervical dilatation plus regular uterine contractions, were randomly allocated to receive either intravenous ritodrine hydrochloride or no tocolytic treatment. Ritodrine treatment significantly delayed delivery for 24 hours or less but did not significantly modify the ultimate perinatal consequences of preterm labour.

UR - http://www.scopus.com/inward/record.url?scp=0022633476&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022633476&partnerID=8YFLogxK

U2 - 10.1016/S0140-6736(86)91219-5

DO - 10.1016/S0140-6736(86)91219-5

M3 - Article

VL - 327

SP - 1293

EP - 1296

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8493

ER -